Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in AVBP — ArriVent BioPharma, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in AVBP

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$712,816
-$4,172,883 QoQ
Shares Held
30,898
-87.3% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVBP Over Time

Shares Held

Position Value (USD)

Derivatives in AVBP

reported options exposure · as of Mar 31, 2026
CallValue
$3,022,170
CallShares
131,000
PutValue
$664,416
PutShares
28,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,176,415,994 across 355 Biotechnology names. AVBP ranks #202 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AVBP

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $712,816 30,898
2026-03-31 $3,022,170 131,000
2026-03-31 $664,416 28,800
2025-12-31 $4,885,699 242,828
2025-09-30 $608,850 33,000
2025-06-30 $644,631 29,611
2025-03-31 $680,265 36,791
2024-12-31 $475,151 17,836